Brief: Alteogen receives China patent
July 17 (Reuters) - Alteogen Inc 196170.KQ :
* Says it receives China patent on July 17, for modified
antibody
in which motif comprising cysteine residue is bound, modified
antibody-drug conjugate comprising the modified antibody, and
production method for same
Source text in Korean : https://goo.gl/2i2WfP
Further company coverage: 196170.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on Alteogen
See all newsDeals of the day-Mergers and acquisitions
Novartis signs deal worth up to $3.2 billion for Alteogen's drug delivery technology
Brief: Alteogen To Invest 253 Billion Won In Construction Of New Factory
Brief: Alteogen Q2 Operating. Profit 34.2 Billion Won
Brief: Alteogen - Signs Exclusive License Agreement For Alt-B4 Recombinant Human Hyaluronidase